CA Patent

CA2893133A1 — Methods of modulating follicle stimulating hormone activity

Assigned to STRASSPHARMA LLC · Expires 2014-06-05 · 12y expired

What this patent protects

Hedgehog pathway modulators, such as hedgehog pathway activators or inhibitors, and the use of such modulators to modulate FSH signaling are described.

USPTO Abstract

Hedgehog pathway modulators, such as hedgehog pathway activators or inhibitors, and the use of such modulators to modulate FSH signaling are described.

Drugs covered by this patent

sonidegib-phosphate (SONIDEGIB PHOSPHATE)

Patent Metadata

Patent number: CA2893133A1
Jurisdiction: CA
Classification: —
Expires: 2014-06-05
Drug substance claim: No
Drug product claim: No
Assignee: STRASSPHARMA LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.